The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 21, 2021

Filed:

Nov. 16, 2016
Applicant:

Ampsource Biopharma Shanghai Inc., Shanghai, CN;

Inventors:

Qiang Li, Shanghai, CN;

Yuanli Li, Shanghai, CN;

Si Chen, Shanghai, CN;

Zhu Wang, Shanghai, CN;

Zhao Dong, Shanghai, CN;

Zirui Li, Shanghai, CN;

Xinlu Ma, Shanghai, CN;

Lu Yang, Shanghai, CN;

Yongjuan Gao, Shanghai, CN;

Yuncheng Zheng, Shanghai, CN;

Naichao Sun, Shanghai, CN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/65 (2017.01); C07K 14/475 (2006.01); C12N 15/62 (2006.01); C12N 15/63 (2006.01); C07K 19/00 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); C07K 14/54 (2006.01); C07K 14/755 (2006.01); C07K 16/06 (2006.01); C07K 16/28 (2006.01); C07K 16/46 (2006.01); C12N 15/85 (2006.01);
U.S. Cl.
CPC ...
A61K 47/65 (2017.08); A61P 3/04 (2018.01); A61P 3/10 (2018.01); C07K 14/475 (2013.01); C07K 14/5418 (2013.01); C07K 14/755 (2013.01); C07K 16/065 (2013.01); C07K 16/2809 (2013.01); C07K 16/2887 (2013.01); C07K 16/468 (2013.01); C07K 19/00 (2013.01); C12N 15/62 (2013.01); C12N 15/63 (2013.01); C12N 15/85 (2013.01);
Abstract

A linker peptide for constructing a fusion protein. The linker peptide comprises a flexible peptide and a rigid peptide. The flexible peptide consists of one or more flexible units. The rigid peptide consists of one or more rigid units. The flexible unit comprises two or more amino acid residues selected from Gly, Ser, Ala, and Thr. The rigid unit comprises a human chorionic gonadotropin β-subunit carboxy-terminal peptide (CTP) bearing a plurality of glycosylation sites. The linker peptide can more effectively eliminate mutual steric hindrance of two fusion molecules, decreasing a reduction/loss of polymerization or activity resulting from improper folding of an active protein or a conformational change. On the other hand, the negatively charged, highly sialylated CTP can resist renal clearance, further prolonging a half-life of a fused molecule and enhancing bioavailability of a fused protein. Furthermore, a protective effect of a glycosylated side chain CTP can lower the protease sensitivity of the linker peptide, making a linker region of the fusion protein less degradable.


Find Patent Forward Citations

Loading…